SENATE 1852118th CongressPlaced on Senate Legislative Calendar under General Orders. Calendar No. 201.

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

Last Action: 9/6/2023

Actions

2023-09-06Placed on Senate Legislative Calendar under General Orders. Calendar No. 201.
2023-09-06Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders without amendment. Without written report.
2023-09-06Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders without amendment. Without written report.
2023-06-15Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
2023-06-07Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2023-06-07Introduced in Senate

CRS Summary

As of 2023-09-06 (25)

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)

Cosponsors (2)

Cory Booker (D-NJ)
Raphael Warnock (D-GA)

Subjects

Blood and blood diseases
Genetics
Health promotion and preventive care
Hereditary and development disorders
Medical research
Research administration and funding

Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.